| HUS Group, the joint authority for Helsinki and Uusimaa | Finland – Pharmaceutical products – Nirsevimabin (Beyfortus 50 mg ja 100 mg injektioneste, | €14.0M | 2024-08-27 |
| HUS Group, the joint authority for Helsinki and Uusimaa | Finland – Pharmaceutical products – Nirsevimabin (Beyfortus 50 mg ja 100 mg injektioneste, | €10.5M | 2025-08-27 |
| Ministry of Social Affairs and Health | Finland – Vaccines – Diphtheria, Tetanus and Pertussis (acellurar component) Booster (dtap | €5.0M | 2025-03-20 |
| Ministry of Social Affairs and Health | Finland – Vaccines – Diphtheria, tetanus, pertussis and polio (DTaP + IPV) vaccine for chi | €3.5M | 2025-07-15 |
| Terveyden ja hyvinvoinnin laitos | Finland – Antithrombotic agents – Enoksapariininatrium 100 mg/ml (1 ml esitäytetty ruisku) | €2.0M | 2025-04-02 |
| Finnish Institute for Health and Welfare | Finland – Vaccines – Inactivated polio vaccine (IPV) and Diphtheria-Tetanus-Pertussis vacc | €1 | 2024-04-15 |